ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674455 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674455; 2) Community: the network communities that were significantly associated with the response to NSC 674455; 3) Molecule: the relationships between components within communities and NSC 674455; 4) MDR: the compounds that were significantly associated with the NSC 674455.

NSC Compound Enrichment Correlation
NSC 267713 Digitoxigenin glycoside 0.0396077140933377 -0.079378058
NSC 281818 Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0396077140933377 -0.13230639
NSC 303861 L-Cysteine analog 0.0396077140933377 0.42785297
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0396077140933377 -0.060922097
NSC 30915 Null 0.0396077140933377 0.60050648
NSC 313681 Oxiperomide(USAN) 0.0396077140933377 0.059149635
NSC 339137 PHYSALOLACTONE 0.0396077140933377 0.41505603
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0396077140933377 0.12747634
NSC 601518 Null 0.0396077140933377 0.6003842
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0396077140933377 0.40419648
Total:85  Current:72    [First] [Prev] [Next] [Last]